Defining the Propofol Binding Site Location on the GABAA Receptor

Moez Bali, Myles Akabas

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

The GABAA receptor is a target of many general anesthetics. The low affinity of general anesthetics has complicated the search for the location of anesthetic binding sites. Attention has focused on two pairs of residues near the extracellular ends of the M2 and M3 membrane-spanning segments, α1Ser270/β2Asn265 (15′ M2) and α1Ala291/β2Met286 (M3). In the 4-Å resolution acetylcholine receptor structure, the aligned positions are separated by ∼10 Å. To determine whether these residues are part of a binding site for propofol, an intravenous anesthetic, we probed propofol's ability to protect cysteines substituted for these residues from modification by the sulfhydryl-specific reagent p-chloromercuribenzene-sulfonate (pCMBS -). pCMBS- reacted with cysteines substituted at the four positions in the absence and presence of GABA. Because propofol binding induces conformational change in the GABAA receptor, we needed to establish a reference state of the receptor to compare reaction rates in the absence and presence of propofol. We compared reaction rates in the presence of GABA with those in the presence of propofol + GABA. The GABA concentration was reduced to give a similar fraction of the maximal GABA current in both conditions. Propofol protected, in a concentration-dependent manner, the cysteine substituted for β2Met286 from reaction with pCMBS-. Propofol did not protect the cysteine substituted for the aligned α 1 subunit position or the 15′ M2 segment Cys mutants in either subunit. We infer that propofol may bind near the extracellular end of the β subunit M3 segment.

Original languageEnglish (US)
Pages (from-to)68-76
Number of pages9
JournalMolecular Pharmacology
Volume65
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Propofol
GABA-A Receptors
Binding Sites
gamma-Aminobutyric Acid
Cysteine
General Anesthetics
Intravenous Anesthetics
Sulfhydryl Reagents
Cholinergic Receptors
Anesthetics
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Defining the Propofol Binding Site Location on the GABAA Receptor. / Bali, Moez; Akabas, Myles.

In: Molecular Pharmacology, Vol. 65, No. 1, 01.2004, p. 68-76.

Research output: Contribution to journalArticle

@article{08d4e8534b334563ac59113a7ba8b727,
title = "Defining the Propofol Binding Site Location on the GABAA Receptor",
abstract = "The GABAA receptor is a target of many general anesthetics. The low affinity of general anesthetics has complicated the search for the location of anesthetic binding sites. Attention has focused on two pairs of residues near the extracellular ends of the M2 and M3 membrane-spanning segments, α1Ser270/β2Asn265 (15′ M2) and α1Ala291/β2Met286 (M3). In the 4-{\AA} resolution acetylcholine receptor structure, the aligned positions are separated by ∼10 {\AA}. To determine whether these residues are part of a binding site for propofol, an intravenous anesthetic, we probed propofol's ability to protect cysteines substituted for these residues from modification by the sulfhydryl-specific reagent p-chloromercuribenzene-sulfonate (pCMBS -). pCMBS- reacted with cysteines substituted at the four positions in the absence and presence of GABA. Because propofol binding induces conformational change in the GABAA receptor, we needed to establish a reference state of the receptor to compare reaction rates in the absence and presence of propofol. We compared reaction rates in the presence of GABA with those in the presence of propofol + GABA. The GABA concentration was reduced to give a similar fraction of the maximal GABA current in both conditions. Propofol protected, in a concentration-dependent manner, the cysteine substituted for β2Met286 from reaction with pCMBS-. Propofol did not protect the cysteine substituted for the aligned α 1 subunit position or the 15′ M2 segment Cys mutants in either subunit. We infer that propofol may bind near the extracellular end of the β subunit M3 segment.",
author = "Moez Bali and Myles Akabas",
year = "2004",
month = "1",
doi = "10.1124/mol.65.1.68",
language = "English (US)",
volume = "65",
pages = "68--76",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Defining the Propofol Binding Site Location on the GABAA Receptor

AU - Bali, Moez

AU - Akabas, Myles

PY - 2004/1

Y1 - 2004/1

N2 - The GABAA receptor is a target of many general anesthetics. The low affinity of general anesthetics has complicated the search for the location of anesthetic binding sites. Attention has focused on two pairs of residues near the extracellular ends of the M2 and M3 membrane-spanning segments, α1Ser270/β2Asn265 (15′ M2) and α1Ala291/β2Met286 (M3). In the 4-Å resolution acetylcholine receptor structure, the aligned positions are separated by ∼10 Å. To determine whether these residues are part of a binding site for propofol, an intravenous anesthetic, we probed propofol's ability to protect cysteines substituted for these residues from modification by the sulfhydryl-specific reagent p-chloromercuribenzene-sulfonate (pCMBS -). pCMBS- reacted with cysteines substituted at the four positions in the absence and presence of GABA. Because propofol binding induces conformational change in the GABAA receptor, we needed to establish a reference state of the receptor to compare reaction rates in the absence and presence of propofol. We compared reaction rates in the presence of GABA with those in the presence of propofol + GABA. The GABA concentration was reduced to give a similar fraction of the maximal GABA current in both conditions. Propofol protected, in a concentration-dependent manner, the cysteine substituted for β2Met286 from reaction with pCMBS-. Propofol did not protect the cysteine substituted for the aligned α 1 subunit position or the 15′ M2 segment Cys mutants in either subunit. We infer that propofol may bind near the extracellular end of the β subunit M3 segment.

AB - The GABAA receptor is a target of many general anesthetics. The low affinity of general anesthetics has complicated the search for the location of anesthetic binding sites. Attention has focused on two pairs of residues near the extracellular ends of the M2 and M3 membrane-spanning segments, α1Ser270/β2Asn265 (15′ M2) and α1Ala291/β2Met286 (M3). In the 4-Å resolution acetylcholine receptor structure, the aligned positions are separated by ∼10 Å. To determine whether these residues are part of a binding site for propofol, an intravenous anesthetic, we probed propofol's ability to protect cysteines substituted for these residues from modification by the sulfhydryl-specific reagent p-chloromercuribenzene-sulfonate (pCMBS -). pCMBS- reacted with cysteines substituted at the four positions in the absence and presence of GABA. Because propofol binding induces conformational change in the GABAA receptor, we needed to establish a reference state of the receptor to compare reaction rates in the absence and presence of propofol. We compared reaction rates in the presence of GABA with those in the presence of propofol + GABA. The GABA concentration was reduced to give a similar fraction of the maximal GABA current in both conditions. Propofol protected, in a concentration-dependent manner, the cysteine substituted for β2Met286 from reaction with pCMBS-. Propofol did not protect the cysteine substituted for the aligned α 1 subunit position or the 15′ M2 segment Cys mutants in either subunit. We infer that propofol may bind near the extracellular end of the β subunit M3 segment.

UR - http://www.scopus.com/inward/record.url?scp=1642495618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642495618&partnerID=8YFLogxK

U2 - 10.1124/mol.65.1.68

DO - 10.1124/mol.65.1.68

M3 - Article

VL - 65

SP - 68

EP - 76

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -